The key risk is dehydration combined with reduced kidney filtration capacity, which is why baseline kidney testing and daily water intake of 34 liters are essential
Retatrutide is particularly vulnerable because of its size and complexity
This bypasses the digestive system while avoiding injections
Unlike semaglutide, which activates only the GLP-1 receptor, or tirzepatide, which targets both GLP-1 and GIP, retatrutide engages three key metabolic receptors simultaneously: GLP-1 receptor curbs appetite, slows gastric emptying, and lowers blood sugar
Increase side effects Combining alcohol with peptides may increase risks like dizziness, nausea, or fatigue
28 The proportion of patients with at least 1 pharmacy claim for hypotensive agents, antilipemic agents, renin-angiotensin-aldosterone system inhibitors, antibacterial agents, analgesics and antipyretics, devices, diabetic testing supplies, diuretics, sympatholytic agents, psychotherapeutic agents, and -adrenergic agents during the pre-index period was calculated